Join Course Directors Drs. Howard B. Goldman and Kristen Scarpato for the 2024 Annual Review Course in Nashville, TN! talkabouturology.net/news_american_…

Register now for the upcoming FREE webinar on January 18 at 3 p.m. EST. Dr. Jayram will focus on Incorporating I-O Therapies in the Treatment Landscape for Patients with Pathologically High-risk Urothelial Carcinoma Originating in the Bladder. talkabouturology.net/news_american_…

Calling all ICS Members! Are you interested in getting more involved with the ICS and helping shape how the society supports #continence specialists? A range of committee vacancies are now available. Check out if your perfect role is here: talkabouturology.net/news_ics/calli…

🆕 New Cheat Sheet on Male Urethral Trauma: A quick reference.

Check this Urological Trauma Cheat Sheet to understand the complexities of anterior and posterior injuries, from aetiology to management.

Download and read it all here:
▶️ uroweb.org/guidelines/uro…

#EAUguidelines

Breaking ground in #ProstateCancer research: A new BAG-1L–specific antibody is developed and validated, offering a crucial tool to explore its biological and clinical relevance. #ReadNow details on UroToday.com talkabouturology.net/news_urotoday/…

Predictors of efficacy of immune checkpoint inhibitors in patients with advanced #UrothelialCarcinoma : a systematic review and meta-analysis. #BeyondTheAbstract with Matteo Ferro, MD, PhD, and Carlo Buonerba, MD. #ReadNow on UroToday.com talkabouturology.net/news_urotoday/…

Chinese subgroup analysis reveals both similar and distinct responses to novel darolutamide combination therapy. Alicia Morgans,MPH Dana-Farber Cancer Institute, and Yao Zhu, PhD delve into the #ARASENS study's impact on the Chinese population. #WatchNow talkabouturology.net/news_urotoday/…

January is Cervical Cancer Awareness Month! Check out our latest article to explore the key aspects of cervical health talkabouturology.net/news_issm/janu…

The risk of dying from prostate cancer is low among older men receiving routine screening, investigators reported in European Urology talkabouturology.net/news_renalandu…

Chemoablation with UGN-102 produced a high complete response rate in patients with low-grade, intermediate-risk non-muscle-invasive bladder cancer (NMIBC) in the phase 3 ENVISION trial. talkabouturology.net/news_renalandu…

Serum neutrophil-to-lymphocyte ratio (NLR) can help differentiate interstitial cystitis/bladder pain syndrome (IC/BPS) from overactive bladder (OAB) talkabouturology.net/news_renalandu…

A pilot study has been initiated to explore the effect of the oral testosterone replacement therapy, testosterone undecanoate, on spermatogenesis in males with hypogonadism. talkabouturology.net/news_urology_t…

Sumit Saini, MD, discusses the current physician shortages and the need to improve diversity in the urology work force. talkabouturology.net/news_urology_t…

Save the date! #UROonco24 will take place in the historic city of Budapest, Hungary, from 20 – 22 June 2024. Get essential updates on genitourinary cancers (PCa, BCa, RCC & rare tumours).

Registration is now open + view the scientific programme
👉 meeting.uroonco.uroweb.org

Anthem Blue Cross and Blue Shield has published a medical policy that includes coverage of the eCoin System implantable tibial nerve stimulation procedure for the treatment of patients with urgency urinary incontinence secondary to overactive bladder. talkabouturology.net/news_urology_t…

Calling all ICS Members! Are you interested in getting more involved with the ICS and helping shape how the society supports #continence specialists? A range of committee vacancies are now available. Check out if your perfect role is here: talkabouturology.net/news_ics/calli…

AUA members receive access to the latest resources for your urology care team. Explore all of the benefits and resources available with your membership! talkabouturology.net/news_american_…

AUA CodingPlus Part Four is available to stream on-demand! Access this can't-miss content today talkabouturology.net/news_american_…

Have you registered for the 2024 Innovation Nexus Conference? You don't want to miss this ground breaking event! For more information or to register, click here talkabouturology.net/news_american_…

Immunotherapy initiation for patients with renal cell carcinoma increased from 0.5% to 2.6% over the course of the study. talkabouturology.net/news_urology_t…